mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0006 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0009 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.001 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
MPS-1-IN-1 |
GDSC1000 |
pan-cancer |
AAC |
0.094 |
0.003 |
mRNA |
Epothilone B |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.003 |